# Imaging Study of a TROP2 Binder in Metastatic UC, HR+ and HER2- Breast Cancer, TNBC, and NSCLC

> clinical trial · VERIFIED · 2026-06-26

Status: NOT_YET_RECRUITING · Sponsor: RayzeBio, Inc. · Condition: Metastatic Urothelial Carcinoma

- Company: RayzeBio, Inc.
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT07671092

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.